A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors
Clinical trial NCT05789537 · TERMINATED
Trial details
- NCT number
- NCT05789537
- Sponsor
- ApcinteX Ltd
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-28
- Primary completion
- 2024-11-14
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.